Gyre Therapeutics (GYRE) Change in Taxes (2023 - 2026)
Gyre Therapeutics (GYRE) posted quarterly Change in Taxes of $144000.0 for Q1 2026, up 106.35% year-over-year from $69782.7 in Q1 2025, and down 44.83% quarter-over-quarter from $261000.0 in Q4 2025.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Change in Taxes (2023 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Change in Taxes for 4 consecutive years, with $144000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Taxes rose 106.35% year-over-year to $144000.0; the TTM figure through Mar 2026 stood at $2.5 million (up 141.91% YoY), while the FY2025 annual figure was $44000.0, up 102.03% from the prior year.
- Change in Taxes eased to $144000.0 in Q1 2026 per GYRE's latest filing, from $261000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $2.5 million in Q3 2023 and bottomed at -$4.2 million in Q2 2024.
- Historically, Change in Taxes has averaged $78846.2 across 4 years, with a median of $261000.0 in 2025.
- On a YoY basis, Change in Taxes climbed as much as 301.54% in 2025 and fell as far as 259.24% in 2025.
- Gyre Therapeutics' Change in Taxes stood at -$185000.0 in 2023, then surged by 135.14% to $65000.0 in 2024, then jumped by 301.54% to $261000.0 in 2025, then plunged by 44.83% to $144000.0 in 2026.
- Business Quant data shows GYRE's Change in Taxes at $144000.0 in Q1 2026, $261000.0 in Q4 2025, and $1.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Gyre Therapeutics | 691.38 Mn | 633.98 Mn | 26.90 Mn | -1.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.02 Mn |
| Mar 31, 2026 | 144,000.00 |
| Dec 31, 2025 | 261,000.00 |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 513,000.00 |
| Mar 31, 2025 | -2.27 Mn |
| Dec 31, 2024 | 65,000.00 |
| Sep 30, 2024 | 535,000.00 |
| Jun 30, 2024 | -4.19 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Dec 31, 2023 | -185,000.00 |
| Sep 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | -1.23 Mn |
| Mar 31, 2023 | 1.92 Mn |